INVESTER I ALTERITY THERAPEUTICS LTD MED ENDAVU: Køb Alterity Therapeutics ltd ($PBN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alterity Therapeutics ltd, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on developing innovative treatments for neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and Huntington disease. Headquartered in Melbourne, Australia, the company’s research centers on disease-modifying therapies, with its lead drug candidate ATH434 targeting Parkinsonian movement disorders and multiple system atrophy. Alterity Therapeutics has advanced ATH434 through Phase I and Phase II clinical trials, demonstrating promising results in early-stage development. The company also maintains a proprietary chemical library and is actively engaged in drug discovery for neurological conditions. Listed on the CHI-X Market Australia – Limit Venue, Alterity Therapeutics operates within a competitive alternative exchange environment, providing investors with access to its shares alongside other major Australian equities. The company’s work contributes to the broader healthcare sector’s efforts to address unmet medical needs in neurodegenerative disorders.